Abstract

Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients (Pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 24 Months of Maintenance
Jacob P Laubach ...
Blood | VOL. 138
Jacob P Laubach, et. al.Jacob P Laubach ...
05 Nov 2021
Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Griffin Study Update
Kenneth H Shain ...
Blood | VOL. 134
Kenneth H Shain, et. al.Kenneth H Shain ...
13 Nov 2019
Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): A Subgroup Analysis of Griffin
...
Blood | VOL. 138
, et. al. ...
05 Nov 2021
Daratumumab (DARA) Plus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of Griffin after 12 Months of Maintenance Therapy
Jonathan L Kaufman ...
Blood | VOL. 136
Jonathan L Kaufman, et. al.Jonathan L Kaufman ...
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Momelotinib for the treatment of myelofibrosis.
Prithviraj Bose
Blood | VOL. -
Prithviraj BosePrithviraj Bose
03 Jul 2024
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.
Samuel C.C Chiang ... Yenan T Bryceson
Blood | VOL. -
Samuel C.C Chiang, et. al.Samuel C.C Chiang ... Yenan T Bryceson
03 Jul 2024
Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications.
Elsa Bernard ... Elli Papaemmanuil
Blood | VOL. -
Elsa Bernard, et. al.Elsa Bernard ... Elli Papaemmanuil
03 Jul 2024
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial.
Lu Sun ... Yu Hou
Blood | VOL. -
Lu Sun, et. al.Lu Sun ... Yu Hou
03 Jul 2024
View more papers